Df. Williamson, WEIGHT-LOSS AND MORTALITY IN PERSONS WITH TYPE-2 DIABETES-MELLITUS - A REVIEW OF THE EPIDEMIOLOGIC EVIDENCE, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106, 1998, pp. 14-20
Six epidemiological studies of weight loss and mortality in persons wi
th diabetes are reviewed in this paper. One study found no relationshi
p between weight loss and mortality, one study (published as an abstra
ct) found that weight loss was associated with reduced mortality, and
in two studies the results were mixed: in some groups weight loss was
associated with increased mortality and in other subgroups weight loss
was associated with reduced mortality. The most appropriate interpret
ation from this group of studies is that the relationship between weig
ht loss and mortality in persons with diabetes is equivocal. None of t
hese studies were designed to experimentally test the hypothesis that
intentional weight loss increases survival in persons with diabetes. B
ecause weight loss was not randomly assigned to the study participants
, and because the reasons that the participants lost weight are not ma
de clear, we can only conjecture about the potential confounding role
that underlying illness plays in accounting for these results. In addi
tion, the epidemiological evidence suggests that persons with diabetes
are more likely than non-diabetics to experience both intentional and
unintentional weight loss. This fact makes it especially difficult to
cleanly separate the potentially opposing effects of intentional and
unintentional weight loss in observational studies. Because of the imp
ortant limitations and inconsistencies in the results of the studies r
eviewed here, the clinical community is left with little guidance on t
he relative role that intentional weight loss should play in the care
of persons with diabetes, compared with better established treatments.
Although better designed observational epidemiological studies are ne
eded the best test of the hypothesis that weight loss improves surviva
l in persons with diabetes will come from randomised controlled trials
.